Prevalence and Associated Factors of Functional Gastrointestinal Disorders Among Children

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05605405
Collaborator
(none)
269
12

Study Details

Study Description

Brief Summary

The definition of Functional Gastrointestinal Disorders (FGIDs) has changed over time from the absence of organic disease to a stress-related or psychiatric disorder to a motility disorder, and with Rome III, to a disorder of GI functioning, then Rome iv in 2016 defined FGIDs as : disorders of gut-brain interaction. It is a group of disorders classified by GI symptoms related to any combination of the following: motility disturbance, visceral hypersensitivity,altered mucosal and immune function, altered gut microbiota, and altered central nervous system (CNS) processing. FGIDs are observed in infants and young children worldwide with variable frequency related studies done in variable places around the worled show the following results : the prevalence of FGIDs in Chinese infants and young children is 27.3%.and 40 % in south american infants and 30 % of african infants and 35.1 % of infants presented to tertiary care hospital in Istunbul.Turkey.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The etiology of these disorders remains uncertain and thought to be due to subtle alteration of the normal development or maladaptive behavioral response to a variety of internal or external stimuli .As a group of disorders; FGIDs in young children are a major challenge to the already overstretched pediatric gastroenterology services across the world .Infants and young children with FGIDs visit medical professionals more frequently and experience poor quality of life . In addition, FGIDs in infancy are linked with detrimental repercussions such as maternal depression, poor infant and mother bonding,and poor physical growth .

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    269 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    Prevalence and Associated Factors of Functional Gastrointestinal Disorders Among Children Attending Assuit University Children Hospital
    Anticipated Study Start Date :
    Dec 1, 2022
    Anticipated Primary Completion Date :
    Sep 1, 2023
    Anticipated Study Completion Date :
    Dec 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Prevalence of functional gastrointestinal disorders among children attending gastrointerology clinic of Assuit University Children Hospital [50 weeks]

      A number will calculated

    2. The associated factors [50 weeks]

      Demographic and social

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Year to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age group 1 to 18 years old
    Exclusion Criteria:
    • Age group bwlow 1 year and above 18 years
    Having other git problem as :
    • GIT bleeding

    • H pylori infection

    • Cow's milk protein allergy or IBD or any other symptoms suggestive to organic GI disease

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Assiut University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ahlam Osama, Prevalence and associated factors of functional gastrointestinal disorders among children attending Assuit University Children Hospital, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05605405
    Other Study ID Numbers:
    • PAAFOFGDACAAUCH
    First Posted:
    Nov 4, 2022
    Last Update Posted:
    Nov 4, 2022
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 4, 2022